Annual EBIT
-$4.89 M
-$1.47 M-43.15%
31 December 2023
Summary:
Protagenic Therapeutics annual earnings before interest & taxes is currently -$4.89 million, with the most recent change of -$1.47 million (-43.15%) on 31 December 2023. During the last 3 years, it has fallen by -$2.59 million (-112.49%). PTIX annual EBIT is now -366.64% below its all-time high of $3.73 million.PTIX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$640.80 K
+$965.70 K+60.11%
30 September 2024
Summary:
Protagenic Therapeutics quarterly earnings before interest & taxes is currently -$640.80 thousand, with the most recent change of +$965.70 thousand (+60.11%) on 30 September 2024. Over the past year, it has increased by +$723.90 thousand (+53.04%). PTIX quarterly EBIT is now -119.42% below its all-time high of $3.30 million, reached on 31 October 1996.PTIX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$5.63 M
+$723.90 K+11.38%
30 September 2024
Summary:
Protagenic Therapeutics TTM earnings before interest & taxes is currently -$5.63 million, with the most recent change of +$723.90 thousand (+11.38%) on 30 September 2024. Over the past year, it has dropped by -$1.84 million (-48.33%). PTIX TTM EBIT is now -270.75% below its all-time high of $3.30 million, reached on 31 October 1996.PTIX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTIX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -43.1% | +53.0% | -48.3% |
| 3 y3 years | -112.5% | +16.1% | -55.4% |
| 5 y5 years | -91.3% | -419.7% | -218.6% |
PTIX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -112.5% | at low | -12.5% | +62.8% | -103.0% | +11.4% |
| 5 y | 5 years | -182.0% | at low | -419.7% | +62.8% | -253.2% | +11.4% |
| alltime | all time | -366.6% | +95.8% | -119.4% | +99.5% | -270.8% | +95.6% |
Protagenic Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$640.80 K(-60.1%) | -$5.63 M(-11.4%) |
| June 2024 | - | -$1.61 M(-6.8%) | -$6.36 M(+7.2%) |
| Mar 2024 | - | -$1.72 M(+3.7%) | -$5.93 M(+21.2%) |
| Dec 2023 | -$4.89 M(+43.1%) | -$1.66 M(+21.9%) | -$4.89 M(+28.8%) |
| Sept 2023 | - | -$1.36 M(+15.8%) | -$3.80 M(+14.2%) |
| June 2023 | - | -$1.18 M(+71.5%) | -$3.33 M(+19.8%) |
| Mar 2023 | - | -$686.80 K(+20.6%) | -$2.78 M(-18.8%) |
| Dec 2022 | -$3.42 M(-15.1%) | -$569.40 K(-36.3%) | -$3.42 M(-7.1%) |
| Sept 2022 | - | -$893.30 K(+42.5%) | -$3.68 M(+3.6%) |
| June 2022 | - | -$627.00 K(-52.8%) | -$3.55 M(-16.1%) |
| Mar 2022 | - | -$1.33 M(+59.8%) | -$4.23 M(+5.1%) |
| Dec 2021 | -$4.03 M(+74.8%) | -$831.10 K(+8.8%) | -$4.03 M(+11.1%) |
| Sept 2021 | - | -$763.80 K(-41.6%) | -$3.63 M(-5.8%) |
| June 2021 | - | -$1.31 M(+16.6%) | -$3.85 M(+26.1%) |
| Mar 2021 | - | -$1.12 M(+160.9%) | -$3.05 M(+27.7%) |
| Dec 2020 | -$2.30 M(+32.7%) | -$430.20 K(-56.4%) | -$2.39 M(-11.3%) |
| Sept 2020 | - | -$987.30 K(+92.7%) | -$2.69 M(+47.2%) |
| June 2020 | - | -$512.40 K(+11.5%) | -$1.83 M(+14.7%) |
| Mar 2020 | - | -$459.60 K(-37.4%) | -$1.60 M(-8.0%) |
| Dec 2019 | -$1.74 M(-32.2%) | -$734.00 K(+495.3%) | -$1.74 M(-1.9%) |
| Sept 2019 | - | -$123.30 K(-55.7%) | -$1.77 M(-17.5%) |
| June 2019 | - | -$278.50 K(-53.5%) | -$2.14 M(-15.9%) |
| Mar 2019 | - | -$599.20 K(-21.9%) | -$2.55 M(-0.3%) |
| Dec 2018 | -$2.56 M(+8.1%) | -$767.70 K(+54.1%) | -$2.56 M(+2.4%) |
| Sept 2018 | - | -$498.10 K(-27.3%) | -$2.50 M(-1.1%) |
| June 2018 | - | -$685.10 K(+12.9%) | -$2.53 M(+9.2%) |
| Mar 2018 | - | -$606.70 K(-14.4%) | -$2.31 M(-2.2%) |
| Dec 2017 | -$2.37 M(+4.3%) | -$708.80 K(+34.5%) | -$2.37 M(+6.9%) |
| Sept 2017 | - | -$527.00 K(+11.7%) | -$2.21 M(+3.3%) |
| June 2017 | - | -$471.60 K(-28.3%) | -$2.14 M(-2.3%) |
| Mar 2017 | - | -$657.90 K(+18.3%) | -$2.19 M(-3.4%) |
| Dec 2016 | -$2.27 M(+369.7%) | -$556.10 K(+22.1%) | -$2.27 M(+21.7%) |
| Sept 2016 | - | -$455.50 K(-12.9%) | -$1.86 M(+21.2%) |
| June 2016 | - | -$522.70 K(-28.8%) | -$1.54 M(+36.6%) |
| Mar 2016 | - | -$734.40 K(+386.4%) | -$1.13 M(+120.2%) |
| Dec 2015 | - | -$151.00 K(+17.1%) | -$511.00 K(+3.2%) |
| Sept 2015 | - | -$129.00 K(+16.2%) | -$495.00 K(+2.7%) |
| June 2015 | -$483.00 K(-47.6%) | -$111.00 K(-7.5%) | -$482.00 K(+0.6%) |
| Mar 2015 | - | -$120.00 K(-11.1%) | -$479.00 K(-35.2%) |
| Dec 2014 | - | -$135.00 K(+16.4%) | -$739.00 K(-11.6%) |
| Sept 2014 | - | -$116.00 K(+7.4%) | -$836.00 K(-9.3%) |
| June 2014 | -$921.00 K(+14.3%) | -$108.00 K(-71.6%) | -$922.00 K(+13.3%) |
| Mar 2014 | - | -$380.00 K(+63.8%) | -$814.00 K(+87.6%) |
| Dec 2013 | - | -$232.00 K(+14.9%) | -$434.00 K(+114.9%) |
| Sept 2013 | - | -$202.00 K(-95.5%) | -$202.00 K(-99.1%) |
| June 2013 | -$806.00 K(-96.1%) | - | - |
| Sept 2011 | - | -$4.47 M(-11.1%) | -$22.28 M(+4.1%) |
| June 2011 | - | -$5.03 M(+45.0%) | -$21.39 M(+2.8%) |
| Mar 2011 | - | -$3.47 M(-62.8%) | -$20.80 M(+1.0%) |
| Dec 2010 | -$20.59 M | -$9.32 M(+159.7%) | -$20.60 M(-32.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | -$3.59 M(-19.1%) | -$30.43 M(-4.6%) |
| June 2010 | - | -$4.43 M(+36.0%) | -$31.90 M(+5.3%) |
| Mar 2010 | - | -$3.26 M(-83.0%) | -$30.30 M(+5.3%) |
| Dec 2009 | -$28.79 M(-75.3%) | -$19.15 M(+278.4%) | -$28.79 M(-77.3%) |
| Sept 2009 | - | -$5.06 M(+78.2%) | -$127.01 M(+3.9%) |
| June 2009 | - | -$2.84 M(+63.2%) | -$122.20 M(+3.9%) |
| Mar 2009 | - | -$1.74 M(-98.5%) | -$117.61 M(+1.2%) |
| Dec 2008 | -$116.50 M(+2018.5%) | -$117.37 M(>+9900.0%) | -$116.25 M(>+9900.0%) |
| Sept 2008 | - | -$245.00 K(-114.0%) | -$32.00 K(-98.3%) |
| June 2008 | - | $1.75 M(-554.0%) | -$1.91 M(-66.0%) |
| Mar 2008 | - | -$385.00 K(-66.5%) | -$5.61 M(+2.1%) |
| Dec 2007 | -$5.50 M(-473.1%) | -$1.15 M(-45.8%) | -$5.50 M(+26.4%) |
| Sept 2007 | - | -$2.12 M(+8.3%) | -$4.35 M(+93.9%) |
| June 2007 | - | -$1.96 M(+622.5%) | -$2.24 M(-14.6%) |
| Mar 2007 | - | -$271.00 K(+1781.9%) | -$2.63 M(+17.5%) |
| Dec 2006 | $1.47 M(-2176.1%) | - | - |
| Oct 2006 | - | -$14.40 K(-99.4%) | -$2.23 M(-1.6%) |
| July 2006 | - | -$2.34 M(-1900.0%) | -$2.27 M(-3347.6%) |
| July 2006 | -$71.00 K(-24.9%) | - | - |
| Apr 2006 | - | $130.00 K(-1440.2%) | $69.90 K(-216.3%) |
| Jan 2006 | - | -$9700.00(-80.8%) | -$60.10 K(+19.2%) |
| Oct 2005 | - | -$50.40 K(-73.6%) | -$50.40 K(-96.7%) |
| July 2005 | -$94.50 K(<-9900.0%) | - | - |
| July 2004 | $0.00(-100.0%) | - | - |
| Apr 2003 | - | -$191.00 K(-51.9%) | -$1.51 M(+7.2%) |
| Jan 2003 | - | -$397.00 K(+2.6%) | -$1.41 M(+17.4%) |
| Oct 2002 | - | -$387.00 K(-27.3%) | -$1.20 M(+126.9%) |
| July 2002 | -$528.00 K(-170.7%) | -$532.00 K(+491.1%) | -$528.00 K(+95.6%) |
| Apr 2002 | - | -$90.00 K(-52.4%) | -$270.00 K(+500.0%) |
| Jan 2002 | - | -$189.00 K(-166.8%) | -$45.00 K(-109.7%) |
| Oct 2001 | - | $283.00 K(-203.3%) | $463.00 K(-38.0%) |
| July 2001 | $747.00 K(-59.3%) | -$274.00 K(-303.0%) | $747.00 K(-50.4%) |
| Apr 2001 | - | $135.00 K(-57.7%) | $1.51 M(-12.7%) |
| Jan 2001 | - | $319.00 K(-43.7%) | $1.73 M(-4.5%) |
| Oct 2000 | - | $567.00 K(+16.7%) | $1.81 M(-3.7%) |
| July 2000 | $1.83 M(-767.3%) | $486.00 K(+37.3%) | $1.88 M(+166.9%) |
| Apr 2000 | - | $354.00 K(-11.5%) | $703.00 K(+199.1%) |
| Jan 2000 | - | $400.00 K(-37.1%) | $235.00 K(+571.4%) |
| Oct 1999 | - | $636.00 K(-192.6%) | $35.00 K(-117.4%) |
| July 1999 | -$275.00 K(-131.8%) | -$687.00 K(+502.6%) | -$201.00 K(-130.8%) |
| Apr 1999 | - | -$114.00 K(-157.0%) | $652.00 K(-44.1%) |
| Jan 1999 | - | $200.00 K(-50.0%) | $1.17 M(+20.7%) |
| Oct 1998 | - | $400.00 K(+141.0%) | $966.00 K(+11.5%) |
| July 1998 | $866.00 K(-244.3%) | $166.00 K(-58.5%) | $866.00 K(+44.3%) |
| Apr 1998 | - | $400.00 K(>+9900.0%) | $600.00 K(+100.0%) |
| Jan 1998 | - | $0.00(-100.0%) | $300.00 K(-250.0%) |
| Oct 1997 | - | $300.00 K(-400.0%) | -$200.00 K(-107.1%) |
| July 1997 | -$600.00 K | -$100.00 K(-200.0%) | $2.80 M(-3.4%) |
| Apr 1997 | - | $100.00 K(-120.0%) | $2.90 M(+3.6%) |
| Jan 1997 | - | -$500.00 K(-115.2%) | $2.80 M(-15.2%) |
| Oct 1996 | - | $3.30 M | $3.30 M |
FAQ
- What is Protagenic Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Protagenic Therapeutics?
- What is Protagenic Therapeutics annual EBIT year-on-year change?
- What is Protagenic Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Protagenic Therapeutics?
- What is Protagenic Therapeutics quarterly EBIT year-on-year change?
- What is Protagenic Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Protagenic Therapeutics?
- What is Protagenic Therapeutics TTM EBIT year-on-year change?
What is Protagenic Therapeutics annual earnings before interest & taxes?
The current annual EBIT of PTIX is -$4.89 M
What is the all time high annual EBIT for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual earnings before interest & taxes is $3.73 M
What is Protagenic Therapeutics annual EBIT year-on-year change?
Over the past year, PTIX annual earnings before interest & taxes has changed by -$1.47 M (-43.15%)
What is Protagenic Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of PTIX is -$640.80 K
What is the all time high quarterly EBIT for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly earnings before interest & taxes is $3.30 M
What is Protagenic Therapeutics quarterly EBIT year-on-year change?
Over the past year, PTIX quarterly earnings before interest & taxes has changed by +$723.90 K (+53.04%)
What is Protagenic Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of PTIX is -$5.63 M
What is the all time high TTM EBIT for Protagenic Therapeutics?
Protagenic Therapeutics all-time high TTM earnings before interest & taxes is $3.30 M
What is Protagenic Therapeutics TTM EBIT year-on-year change?
Over the past year, PTIX TTM earnings before interest & taxes has changed by -$1.84 M (-48.33%)